Table 1 Baseline clinical data of control subjects and patients with hodgkin lymphoma.

Number

23

23

Age, years

46.16 ± 14.58

49.87 ± 19.85

ns

Female, n (%)

10 (43%)

9 (39%)

ns

Hemoglobin, g/L

138.4 ± 20.13

129.5 ± 12.9

ns

Red blood cells, millions/µL

4.80 ± 0.53

4.75 ± 0.33

ns

Platelets, thousands/µL

245 ± 57

325 ± 130

p < 0.05

White blood cells, thousands/µL

6.28 ± 1.5

10.1 ± 3.1

p < 0.01

Neutrophils, thousands/µL

3.39 ± 0.86

7.50 ± 3.00

p < 0.01

Monocytes, thousands/µL

0.5 ± 0.14

0.85 ± 0.35

p < 0.01

Lymphocytes, thousands/µL

2.22 ± 0.67

1.51 ± 0.52

p < 0.01

Ann Arbor classification, n (%)

Stage II

10 (43%)

Stage III

5 (22%)

Stage IV

8 (35%)

Histology

Classical

14

Nodular sclerosis

9